Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R.
???displayArticle.abstract???
Andersen syndrome (AS) is a rare, inherited disorder characterized by periodic paralysis, long QT (LQT) with ventricular arrhythmias, and skeletal developmental abnormalities. We recently established that AS is caused by mutations in KCNJ2, which encodes the inward rectifier K(+) channel Kir2.1. In this report, we characterized the functional consequences of three novel and seven previously described KCNJ2 mutations using a two-microelectrode voltage-clamp technique and correlated the findings with the clinical phenotype. All mutations resulted in loss of function and dominant-negative suppression of Kir2.1 channel function. In mutation carriers, the frequency of periodic paralysis was 64% and dysmorphic features 78%. LQT was the primary cardiac manifestation, present in 71% of KCNJ2 mutation carriers, with ventricular arrhythmias present in 64%. While arrhythmias were common, none of our subjects suffered sudden cardiac death. To gain insight into the mechanism of arrhythmia susceptibility, we simulated the effect of reduced Kir2.1 using a ventricular myocyte model. A reduction in Kir2.1 prolonged the terminal phase of the cardiac action potential, and in the setting of reduced extracellular K(+), induced Na(+)/Ca(2+) exchanger-dependent delayed afterdepolarizations and spontaneous arrhythmias. These findings suggest that the substrate for arrhythmia susceptibility in AS is distinct from the other forms of inherited LQT syndrome.
Andersen,
Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?
1971, Pubmed
Andersen,
Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?
1971,
Pubmed Canún,
Andersen syndrome autosomal dominant in three generations.
1999,
Pubmed Fukuda,
Long-standing bidirectional tachycardia in a patient with hypokalemic periodic paralysis.
1988,
Pubmed Griggs,
Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness.
1970,
Pubmed January,
Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.
1989,
Pubmed Keating,
Molecular and cellular mechanisms of cardiac arrhythmias.
2001,
Pubmed Keating,
Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene.
1991,
Pubmed Kimbrough,
Clinical implications for affected parents and siblings of probands with long-QT syndrome.
2001,
Pubmed KLEIN,
J Periodic paralysis with cardiac arrhythmia.
1963,
Pubmed Krishnamani,
Bidirectional ventricular tachycardia and familial periodic paralysis: a case report.
1999,
Pubmed Kubo,
Primary structure and functional expression of a mouse inward rectifier potassium channel.
1993,
Pubmed
,
Xenbase Laitinen,
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.
2001,
Pubmed Levi,
Role of intracellular sodium overload in the genesis of cardiac arrhythmias.
1997,
Pubmed McManis,
The exercise test in periodic paralysis.
1986,
Pubmed Plaster,
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.
2001,
Pubmed
,
Xenbase Priori,
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
2001,
Pubmed Puglisi,
LabHEART: an interactive computer model of rabbit ventricular myocyte ion channels and Ca transport.
2001,
Pubmed Raab-Graham,
Molecular cloning and expression of a human heart inward rectifier potassium channel.
1994,
Pubmed
,
Xenbase Sansone,
Andersen's syndrome: a distinct periodic paralysis.
1997,
Pubmed Schwartz,
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
2001,
Pubmed Shimoni,
Role of an inwardly rectifying potassium current in rabbit ventricular action potential.
1992,
Pubmed Soom,
Multiple PIP2 binding sites in Kir2.1 inwardly rectifying potassium channels.
2001,
Pubmed
,
Xenbase Stubbs,
Bidirectional ventricular tachycardia in familial hypokalaemic periodic paralysis.
1976,
Pubmed Surawicz,
U wave: facts, hypotheses, misconceptions, and misnomers.
1998,
Pubmed Tawil,
Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis.
2000,
Pubmed Tawil,
Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features.
1994,
Pubmed Tinker,
Regions responsible for the assembly of inwardly rectifying potassium channels.
1996,
Pubmed
,
Xenbase Tristani-Firouzi,
Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits.
1998,
Pubmed
,
Xenbase Weingart,
Is digitalis inotropy associated with enhanced slow inward calcium current?
1978,
Pubmed Wible,
Cloning and functional expression of an inwardly rectifying K+ channel from human atrium.
1995,
Pubmed
,
Xenbase Zareba,
Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.
1998,
Pubmed Zhang,
Activation of inwardly rectifying K+ channels by distinct PtdIns(4,5)P2 interactions.
1999,
Pubmed
,
Xenbase
